Investors
3 investorsAll
Early stage
Mid stage
Late stage
Mid stage· 1
Stéphane Thiroloix
Fractional CEO, APIKAL Therapeutics
Board Member
mid stage
4 investments
2007
Other investors· 2
Timothy E. Morris
CFO & COO I Venture Partner, LongeVC I Board Member I DBV Technologies S.A. (Euronext: DBV, NASDAQ: DBVT), Aquestive Therapeutics (NASDAQ: AQST), Humanetics Pharmaceuticals, (private), CPA (retired)
Non Executive Board Member
6 investments
Apr 2021
Jens Bager
Chair and Investor
Board member
3 investments
2008
Investor geography3 countries
Investor activity2007–2021 · investors recorded per year
Recent (last 2y)Earlier
Frequently asked questions
Who invested in DBV Technologies?
DBV Technologies has 3 investors on record on gritt.io, 1 mid-stage.
When did DBV Technologies last raise funding?
The most recent investment in DBV Technologies recorded on gritt.io was in April 2021.
What industry is DBV Technologies in?
DBV Technologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is DBV Technologies based?
DBV Technologies is headquartered in Montrouge, France.
